Cargando…
PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429611/ http://dx.doi.org/10.1097/01.HS9.0000975316.44667.ed |
| _version_ | 1785090758163824640 |
|---|---|
| author | Du, Juan He, Haiyan Fan, Xiangqiang Jin, Lina Lu, Jing Qiang, Wanting Liu, Jin |
| author_facet | Du, Juan He, Haiyan Fan, Xiangqiang Jin, Lina Lu, Jing Qiang, Wanting Liu, Jin |
| author_sort | Du, Juan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104296112023-08-17 PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION Du, Juan He, Haiyan Fan, Xiangqiang Jin, Lina Lu, Jing Qiang, Wanting Liu, Jin Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429611/ http://dx.doi.org/10.1097/01.HS9.0000975316.44667.ed Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Du, Juan He, Haiyan Fan, Xiangqiang Jin, Lina Lu, Jing Qiang, Wanting Liu, Jin PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION |
| title | PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION |
| title_full | PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION |
| title_fullStr | PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION |
| title_full_unstemmed | PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION |
| title_short | PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION |
| title_sort | pb2138: oral regimen selinexor, pomalidomide, and dexamethasone in relapsed and/or refractory multiple myeloma (rrmm): safety assessment and optimization |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429611/ http://dx.doi.org/10.1097/01.HS9.0000975316.44667.ed |
| work_keys_str_mv | AT dujuan pb2138oralregimenselinexorpomalidomideanddexamethasoneinrelapsedandorrefractorymultiplemyelomarrmmsafetyassessmentandoptimization AT hehaiyan pb2138oralregimenselinexorpomalidomideanddexamethasoneinrelapsedandorrefractorymultiplemyelomarrmmsafetyassessmentandoptimization AT fanxiangqiang pb2138oralregimenselinexorpomalidomideanddexamethasoneinrelapsedandorrefractorymultiplemyelomarrmmsafetyassessmentandoptimization AT jinlina pb2138oralregimenselinexorpomalidomideanddexamethasoneinrelapsedandorrefractorymultiplemyelomarrmmsafetyassessmentandoptimization AT lujing pb2138oralregimenselinexorpomalidomideanddexamethasoneinrelapsedandorrefractorymultiplemyelomarrmmsafetyassessmentandoptimization AT qiangwanting pb2138oralregimenselinexorpomalidomideanddexamethasoneinrelapsedandorrefractorymultiplemyelomarrmmsafetyassessmentandoptimization AT liujin pb2138oralregimenselinexorpomalidomideanddexamethasoneinrelapsedandorrefractorymultiplemyelomarrmmsafetyassessmentandoptimization |